Orlando Agrippa

Empowering Founders to Flourish The way we experience healthcare, live consciously, work productively, shop experientially and grow our wealth is transforming at rapid pace. We invest in world-positive entrepreneurs re-imagining this future. We believe in backing founders from all walks of life. And we mean it. We know there is value beyond capital. And we deliver it. We feel inspired by the innovations transforming how we live and work. And we are committed to empowering that change. We invest at the earliest of stages (pre-seed and seed) and build empowering relationships with the founders we fund, providing unparalleled access to expertise, network, support, and capital. We apply a diversification lens on every investment opportunity, backing daring founders who are closing gaps and addressing underserved needs in bold, unconventional, and creative ways. And we’ve proven the outsized impact this strategy delivers.

Dai delivers comfort-empowered performance for women everyday, everywhere. Certified B Corp. Carbon neutral and 50%+ biodegradable or recycled yarns in 2021. We innovate apparel at the intersection of technical, eco-friendly fabrics, elegant tailoring and versatile, functional design for the modern professional woman. We are a digitally native, direct-to-consumer e-commerce brand bringing premium European craftsmanship to the global contemporary womenswear market. Beyond products, we are a proud Certified B Corporation® committed to doing better for our planet and people. Since launching in July 2017, Dai has continued to grow with its strong USP, proven product/market fit and traction, and consistent coverage in global media outlets including The Times, Financial Times, The Economist and Fast Company. Dai has been recognised in numerous awards for its pioneering work in sustainability and social impact. We are now hiring to continue our high-growth journey to revolutionise the global womenswear market through innovation and sustainability. Dai is committed to building a diverse and inclusive team and is proud to be an equal opportunity employer. All applicants and employees receive equal treatment regardless of race, nationality, ethnic or national origin, religion or belief, sex or sexual orientation, gender, age, disability, marital or civil partner status, pregnancy or maternity. We are committed to building an inclusive environment and culture where everyone can bring their authentic selves to work and reach their full potential within their roles using a growth mindset.

SonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent glioblastoma multiforme (rGBM) and other deadly cancers. SDT utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells.

Unlock the AI-Powered Conversational Data Intelligence for Healthcare Marketing Excellence Talking Medicines is transforming Healthcare Marketing by leveraging Advanced Data Science, Curated Large Language Models (LLMs), and Artificial Intelligence. Our mission is to unlock strategic intelligence within Healthcare Professional (HCPs) and Patient Conversational Data, providing actionable intelligence for Healthcare Marketing Agencies. Advanced-Data Science: Utilize cutting-edge data science techniques to analyze vast amounts of HCP and Patient Conversational Data, uncovering unseen intelligence that drive strategic decision-making. Curated Large Language Models: Implement expertly curated LLMs to accurately interpret and understand the difference in healthcare conversations for actionable Intelligence. Artificial Intelligence: Harness the power of AI to process and analyze Conversational Data, transforming raw information into strategic intelligence that enhances marketing efforts and ROI. Natural Language Interface: Delivers intelligence to customers through an intuitive natural language interface, making it easy to access and understand complex data. Just ask Drug-GPT what you want to know! At Talking Medicines, we are committed to revolutionizing Healthcare Marketing by providing our customers with the tools and intelligence they need to succeed in an increasingly complex and data-driven world.   Learn more: https://www.talkingmedicines.com

Freauty is a marketplace fully dedicated to finding mobile beauty professionals that come to your home, office or choice of venue. Beauty professionals and businesses use Freauty to showcase their services and attract more appointments, and customers want to use Freauty for the convenient pampering treatments at home.

Modex is a market leader in web3 monetization. It helps businesses implement strategies that empower them to capitalize on web3 technology to unlock new revenue streams and increase engagement. Modex bridges the gap from web2, ensuring that businesses aren’t left behind in the quest to explore the exciting frontier of blockchain technology and capture the unique opportunities it presents.

Empowering Founders to Flourish The way we experience healthcare, live consciously, work productively, shop experientially and grow our wealth is transforming at rapid pace. We invest in world-positive entrepreneurs re-imagining this future. We believe in backing founders from all walks of life. And we mean it. We know there is value beyond capital. And we deliver it. We feel inspired by the innovations transforming how we live and work. And we are committed to empowering that change. We invest at the earliest of stages (pre-seed and seed) and build empowering relationships with the founders we fund, providing unparalleled access to expertise, network, support, and capital. We apply a diversification lens on every investment opportunity, backing daring founders who are closing gaps and addressing underserved needs in bold, unconventional, and creative ways. And we’ve proven the outsized impact this strategy delivers.

Sanius Health is a London based, patient-owned company which focuses primarily on patients living with rare and chronic diseases at a global level. Our approach to improving outcomes and access to new medicines focuses on combining live remote monitoring, patient genomics, secondary care, primary care, and patient-reported outcomes data in several targeted domains.

Dai delivers comfort-empowered performance for women everyday, everywhere. Certified B Corp. Carbon neutral and 50%+ biodegradable or recycled yarns in 2021. We innovate apparel at the intersection of technical, eco-friendly fabrics, elegant tailoring and versatile, functional design for the modern professional woman. We are a digitally native, direct-to-consumer e-commerce brand bringing premium European craftsmanship to the global contemporary womenswear market. Beyond products, we are a proud Certified B Corporation® committed to doing better for our planet and people. Since launching in July 2017, Dai has continued to grow with its strong USP, proven product/market fit and traction, and consistent coverage in global media outlets including The Times, Financial Times, The Economist and Fast Company. Dai has been recognised in numerous awards for its pioneering work in sustainability and social impact. We are now hiring to continue our high-growth journey to revolutionise the global womenswear market through innovation and sustainability. Dai is committed to building a diverse and inclusive team and is proud to be an equal opportunity employer. All applicants and employees receive equal treatment regardless of race, nationality, ethnic or national origin, religion or belief, sex or sexual orientation, gender, age, disability, marital or civil partner status, pregnancy or maternity. We are committed to building an inclusive environment and culture where everyone can bring their authentic selves to work and reach their full potential within their roles using a growth mindset.

SonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent glioblastoma multiforme (rGBM) and other deadly cancers. SDT utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells.

Unlock the AI-Powered Conversational Data Intelligence for Healthcare Marketing Excellence Talking Medicines is transforming Healthcare Marketing by leveraging Advanced Data Science, Curated Large Language Models (LLMs), and Artificial Intelligence. Our mission is to unlock strategic intelligence within Healthcare Professional (HCPs) and Patient Conversational Data, providing actionable intelligence for Healthcare Marketing Agencies. Advanced-Data Science: Utilize cutting-edge data science techniques to analyze vast amounts of HCP and Patient Conversational Data, uncovering unseen intelligence that drive strategic decision-making. Curated Large Language Models: Implement expertly curated LLMs to accurately interpret and understand the difference in healthcare conversations for actionable Intelligence. Artificial Intelligence: Harness the power of AI to process and analyze Conversational Data, transforming raw information into strategic intelligence that enhances marketing efforts and ROI. Natural Language Interface: Delivers intelligence to customers through an intuitive natural language interface, making it easy to access and understand complex data. Just ask Drug-GPT what you want to know! At Talking Medicines, we are committed to revolutionizing Healthcare Marketing by providing our customers with the tools and intelligence they need to succeed in an increasingly complex and data-driven world.   Learn more: https://www.talkingmedicines.com